Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomonas aeruginosa pneumonia.

Javier Garau1, Lucia Gomez

  • 1Department of Medicine, Hospital Mutua de Terrassa, University of Barcelona, Spain. jagarau@terra.es

Current Opinion in Infectious Diseases
|May 8, 2003
PubMed
Summary

Pseudomonas aeruginosa is a significant cause of respiratory infections, especially in ventilated patients and those with cystic fibrosis. Optimizing antibiotic therapy using PK/PD concepts and inhaled antibiotics like tobramycin is crucial for managing these difficult-to-treat infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline asymptomatic bacteriuria in high-risk hematological patients: Does low concordance adequately reflect its true invasive potential? Author's reply.

European journal of internal medicine·2026
Same author

Developmental gene expression patterns driving species-specific cortical features.

Nature·2026
Same author

Determining the optimal antibiotic duration for skin and soft tissue infections.

Current opinion in infectious diseases·2025
Same author

Triple M overlap syndrome following pembrolizumab treatment: importance of multidisciplinary approach.

BMJ case reports·2025
Same author

Computational diplomacy: how 'hackathons for good' feed a participatory future for multilateralism in the digital age.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
Same author

Spontaneous Wing Tip Edema in Captive Birds of Prey: Review of 41 Cases in the United Kingdom (2004-2022).

Journal of avian medicine and surgery·2024

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Microbiology

Background:

  • Pseudomonas aeruginosa (P. aeruginosa) is a critical pathogen in respiratory tract infections.
  • It is a common cause of community-acquired pneumonia (CAP) and ventilator-associated pneumonia (VAP).
  • Chronic P. aeruginosa infections are prevalent in cystic fibrosis (CF) patients.

Purpose of the Study:

  • To review recent clinical articles on P. aeruginosa respiratory tract infections.
  • To highlight P. aeruginosa's role in CAP, VAP, and CF infections.
  • To discuss diagnostic and therapeutic challenges.

Main Methods:

  • Literature review of recent articles on P. aeruginosa respiratory infections.
  • Analysis of P. aeruginosa's prevalence and virulence factors.

Related Experiment Videos

  • Evaluation of antibiotic resistance and therapeutic strategies.

    • Main Results:

    • P. aeruginosa is increasingly implicated in CAP and is a major cause of late VAP.
    • Antibiotic administration can affect bacterial recovery in respiratory samples, but P. aeruginosa remains detectable longer than other organisms.
    • Type III secretory proteins are key virulence factors, and fluoroquinolones contribute to multiply resistant P. aeruginosa emergence.
    • Pharmacokinetic/pharmacodynamic (PK/PD) parameters are vital for optimizing antibiotic therapy.
    • Inhaled tobramycin shows long-term benefits for lung function in CF patients.

    Conclusions:

    • P. aeruginosa remains a global challenge in respiratory infections, particularly in VAP and CF.
    • Microbiologic diagnosis is complex and prone to errors.
    • PK/PD concepts are essential for optimizing antibiotic treatment of P. aeruginosa infections.
    • Inhaled antibiotics, such as tobramycin, are increasingly important for P. aeruginosa management in CF.